DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
18.22
-0.16 (-0.87%)
Sep 16, 2026, 3:00 PM CST

SHA:603233 Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, SHA:603233 stock has a consensus rating of "Buy" and an average price target of ¥23.75. The average 1-year stock price forecast is 30.35% higher than the current stock price, while the lowest is ¥15.00 (-17.67%) and the highest is ¥26.40 (+44.90%).

Price Target: ¥23.75 (+30.35%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥15.00¥23.75¥24.30¥26.40
Change-17.67%+30.35%+33.37%+44.90%

Analyst Ratings

The average analyst rating for SHA:603233 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy666666
Buy344455
Hold110000
Sell000000
Strong Sell000001
Total101110101112

Financial Forecast

Revenue This Year
29.54B
from 27.50B
Increased by 7.41%
Revenue Next Year
32.52B
from 29.54B
Increased by 10.09%
EPS This Year
1.31
from 1.07
Increased by 22.33%
EPS Next Year
1.52
from 1.31
Increased by 16.48%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
16.76B21.25B24.53B26.50B27.50B29.54B
Revenue Growth
14.93%26.78%15.45%8.01%3.80%7.41%
Gross Profit
6.37B8.02B8.74B9.07B9.41B10.21B
Gross Margin
38.03%37.76%35.61%34.25%34.22%34.57%
Operating Income
1.10B1.59B1.80B1.55B2.04B2.32B
Net Income
791.23M1.04B1.17B914.75M1.24B1.49B
EPS
----1.071.31
EPS Growth
----36.77%22.33%
Forward PE
28.0631.3723.7616.4416.9713.96
Dividend / Share
0.350.500.310.620.830.94
Dividend Growth
-24.99%43.97%-38.00%100.00%33.87%13.47%
Free Cash Flow
412.54M2.19B2.26B2.07B3.86B1.72B
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High30.4B
Avg29.5B
Low28.6B

Revenue Growth

Revenue Growth202620272028
High
10.4%
Avg
7.4%
Low
4.0%

EPS Forecast

EPS202620272028
High1.32
Avg1.31
Low1.29

EPS Growth

EPS Growth202620272028
High
23.7%
Avg
22.3%
Low
20.9%